Published document record
NDSG workplan 2026-2028 (v2.0)
PDF source copies
These PDFs are hosted here for continued access. Each is labelled as an unmodified official PDF or a converted reading copy. They are saved copies, not a live statement of the latest law or institutional endorsement. Official source links remain below.
Official PDF — unmodified source copy
If the PDF does not display in your browser, Open PDF in a new tab or download it below. Both use the copy hosted on this site.
Download PDF — 36 pages (0.61 MB)Version 2.0. Version 2.0 - February 2026.
Source: European Medicines Agency. Retrieved 2026-09-10.
Copy provenance and reuse
Unmodified source PDF. Source attribution and original notices are retained; see the source reuse terms. Source reuse terms. The database metadata licence does not replace these terms.
SHA-256:
9a71bb191807f899f1a63867c4a30aec366b35d15bf1189413ea4f2ff793b101
Official metadata
- Official title
- NDSG workplan 2026-2028: Data and AI in medicines regulation
- Official reference
- Version 2.0
- Document type
- Work programme
- Document date
- 2026-03-09
- Document date kind
- Publication
- Document-date evidence
- European Medicines Agency · EMA NDSG catalogue Workplan section: 2026-2028 workplan First published 09/03/2026; page update history records publication of the revised workplan that day. — Exact official publication/update fallback for this hosted revision; the cover supplies only an issue month.
- Publication date
- 2026-03-09
- Publication-date evidence
- European Medicines Agency · EMA NDSG catalogue Workplan section: 2026-2028 workplan First published 09/03/2026; page update history records publication of the revised workplan that day. — Official publication of the v2.0 workplan on 9 March 2026, before the fixed cutoff.
- Additional official dates
- Cover issue: 2026-02 (month) · European Medicines Agency · PDF cover: VERSION 2.0, February 2026.
- Institutional adoption: 2026-02 (month) · European Medicines Agency · PDF p.4 Introduction explicitly states that the current workplan was adopted by NDSG in February 2026; no exact adoption day established.
- Version label
- Version 2.0 - February 2026
- Legal status
- Non binding
- Legal-status evidence
- European Medicines Agency · PDF cover identifies workplan; p.4 Introduction describes advisory-group activities and annual updating; AI workstream lists planned deliverables. — Non-binding institutional work programme, not a legislative act.
- Language
- en
Research classifications
These are researcher classifications used to organise and analyse the corpus; they are not official EU metadata.
- Record level
- Version
- Version status
- Revised
- Temporal collection
- Contemporary EU AI policy
- Relevance class
- Direct AI relevance
- Policy stage
- Coordination
- Corpus tier
- Directly related
- Sectors
- Policy membership
Classification evidence
- Relevance class: Direct AI relevance · European Medicines Agency · PDF pp.17-21: Artificial Intelligence workstream; p.18 overview; p.19 Guidance, policy and product support. — Dedicated substantive AI governance, guidance and tools workstream.
- Sector tags: Health · European Medicines Agency · PDF p.4 Introduction and pp.18-19 AI overview and guidance: human and veterinary medicines, public and animal health. — AI evaluation and safe use throughout the medicines lifecycle.
- Sector tags: Public administration · European Medicines Agency · PDF p.20 Tools and Innovation; p.21 Collaboration and change management. — AI tools, regulatory staff capacity and network governance for medicines authorities.
- Sector tags: Research and innovation · European Medicines Agency · PDF p.20 Tools and Innovation: AI research priorities, tools development and innovation; p.21 sandbox simulation hackathon. — Explicit AI research priorities, experimentation and collaborative innovation.
- Provenance tags: Authored by an EU agency or body · European Medicines Agency · PDF cover and p.4 Introduction: Joint HMA/EMA Network Data Steering Group. — Workplan authored by the joint regulatory steering group involving EMA; HMA is a network of national authorities.
- Provenance tags: Joint institutional · European Medicines Agency · PDF cover credits Joint HMA/EMA Network Data Steering Group. — Explicit joint network authorship, distinct from EMA hosting and publication.
- Provenance tags: Officially published · European Medicines Agency · EMA NDSG catalogue Workplan section: 2026-2028 workplan First published 09/03/2026; page update history records publication of the revised workplan that day. — EMA officially distributes this independently citable English workplan version.
Production provenance
- Provenance tags
- Named bibliographic authors
- Joint HMA/EMA Network Data Steering Group · European Medicines Agency · PDF cover; p.4 Introduction.
- Institutions and roles
-
- European Medicines Agency · Official host · role evidence · EMA official documents repository hosts this English PDF.
- European Medicines Agency · Publisher · role evidence · EMA NDSG catalogue, Workplan section, document entry and official English download.
- Joint HMA/EMA Network Data Steering Group · Adopter · role evidence · PDF p.4 Introduction: current first annual revision was adopted by NDSG in February 2026.
- Joint HMA/EMA Network Data Steering Group · Author · role evidence · PDF cover credits Joint HMA/EMA Network Data Steering Group; p.4 Introduction describes the joint strategic advisory group.
Official sources and identifiers
- Official source · Publisher/host: European Medicines Agency
- Official source · Publisher/host: European Medicines Agency
Previous and next versions
-
Previous version: NDSG workplan 2025-2028 (v1.4)
Revises · Official relationship · Verified
Research assessment
- Inclusion rationale
- Joint HMA/EMA NDSG institutional workplan with an extensive dedicated AI workstream for the European medicines regulatory network, including AI guidance, regulatory tools and research.
- Researcher notes
- The cover issue and NDSG adoption are February 2026 at month precision. The 11 February meeting endorsed the plan in principle pending written adoption; it does not establish a final adoption day. EMA's official catalogue links v1.4 as the previous version; v2.0 is the first annual revision. Earlier v1.0-v1.3 manifestations have not been recovered and no complete version history or canonical parent is invented. Future deliverables remain plans. Reviewer attribution denotes AI-assisted evidence review.
- Review status
- verified
Relationships
No additional published relationships touch this record.
Verification
- Expanded evidence review
- Verified
- Reviewed by
- Yichen Hao
- Evidence review date
- 2026-09-06T01:28:20Z
The evidence review date is not a separate human sign-off date. Review credit and evidence-review actions
- Last verified: 2026-09-06T01:28:20Z · EMA NDSG catalogue gives first published 09/03/2026 and links predecessor 2025-2028. Follow-up 6 September 2026: Previous-version download independently identified as Version 1.4, July 2025, last updated 22/07/2025. Current workplan first published 09/03/2026 and revision publication corroborated by page update history. Earlier manifestations remain unrecovered; publication dates are version-specific.
- Last verified: 2026-09-06T01:28:20Z · Prior review (5 September 2026, before this admission): Cover and pp.4-6 reviewed; Version 2.0, February 2026. Pending only because canonical predecessor endpoint is missing. Follow-up 6 September 2026: Full 36-page v2.0 inspected; cover February 2026 and p.4 adoption month/first annual revision verified; AI pp.17-21 checked. New retrieval 2026-09-06T01:12:53.554849+00:00, 640017 bytes, SHA-256 9a71bb191807f899f1a63867c4a30aec366b35d15bf1189413ea4f2ff793b101; local snapshot work/remaining-three-20260906/ndsg-2026-v2-0.pdf. The prior predecessor hold is resolved by admitting v1.4 and the evidenced revision edge.